These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17079846)

  • 1. [Functional mechanism of glucocorticoid in bone turnover and bone structure].
    Ikeda S; Akahoshi S; Sakai A; Nakamura T
    Clin Calcium; 2006 Nov; 16(11):1805-11. PubMed ID: 17079846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
    Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
    Li M; Saito T; Amizuka N
    Clin Calcium; 2008 Mar; 18(3):328-35. PubMed ID: 18310820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism.
    Scholz-Ahrens KE; Delling G; Stampa B; Helfenstein A; Hahne HJ; Açil Y; Timm W; Barkmann R; Hassenpflug J; Schrezenmeir J; Glüer CC
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E385-95. PubMed ID: 17456640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of apoptosis in osteoporosis induced by glucocorticoids.
    Spreafico A; Frediani B; Francucci CM; Capperucci C; Chellini F; Galeazzi M
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):22-7. PubMed ID: 18791347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical markers of bone turnover. New aspect. Biochemical bone markers of bone in patients treated with glucocorticoid].
    Yamauchi M
    Clin Calcium; 2009 Aug; 19(8):1092-1100. PubMed ID: 19638692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucocorticoids and osteoporosis].
    Zikán V
    Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.
    Akahoshi S; Sakai A; Arita S; Ikeda S; Morishita Y; Tsutsumi H; Ito M; Shiraishi A; Nakamura T
    J Bone Miner Metab; 2005; 23(5):341-50. PubMed ID: 16133683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone quality in glucocorticoid induced osteoporosis].
    Sohen S
    Clin Calcium; 2004 Apr; 14(4):568-72. PubMed ID: 15577012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)].
    Masaki H; Miki T
    Clin Calcium; 2006 Nov; 16(11):1823-32. PubMed ID: 17079849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
    Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of glucocorticoid on bone-forming and bone-resorbing cells].
    Hakeda Y
    Clin Calcium; 2006 Nov; 16(11):1817-22. PubMed ID: 17079848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of antiresorptive therapy on the structural and material properties of bone strength].
    Kishimoto H
    Clin Calcium; 2016 Jan; 26(1):107-15. PubMed ID: 26728537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.
    Alesci S; De Martino MU; Ilias I; Gold PW; Chrousos GP
    Neuroimmunomodulation; 2005; 12(1):1-19. PubMed ID: 15756049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cortisone-induced osteoporosis: from physiopathogenesis to treatment].
    Peretz A
    Rev Med Brux; 1991 Oct; 12(8):321-8. PubMed ID: 1947526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers in glucocorticoid-induced osteoporosis.
    Minisola S; Del Fiacco R; Piemonte S; Iorio M; Mascia ML; Fidanza F; Cipriani C; Raso I; Porfiri ML; Francucci CM; D'Erasmo E; Romagnoli E
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):28-32. PubMed ID: 18791348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy.
    Söderpalm AC; Magnusson P; Ahlander AC; Karlsson J; Kroksmark AK; Tulinius M; Swolin-Eide D
    Neuromuscul Disord; 2007 Dec; 17(11-12):919-28. PubMed ID: 17627820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-induced osteoporosis.
    Bockman RS; Weinerman SA
    Orthop Clin North Am; 1990 Jan; 21(1):97-107. PubMed ID: 2404239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
    Takayanagi R
    Clin Calcium; 2007 Feb; 17(2):270-4. PubMed ID: 17272886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanana I; Oshima H
    Clin Calcium; 2006 Nov; 16(11):1851-7. PubMed ID: 17079852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.